See also this year's filing and all EDGAR filings for this company.
PDF Report 0001719406_2024_NRX_Pharmaceuticals_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001719406, NRX Pharmaceuticals Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 6,884,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 431,000 |
| 4 | LiabilitiesCurrent | 19,048,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 14,216,000 |
| 9 | ResearchAndDevelopmentExpense | 13,371,000 |
| 10 | remainder_Expenses | 259,000 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | -2,313,000 |
| 13 | remainder_ComprehensiveNetIncome | -6,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 7,315,000 |
| 1 | Liabilities | 19,048,000 |
| 2 | Expenses | 27,846,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | -11,733,000 |
| 5 | NetIncome | -30,159,000 |
| 6 | ComprehensiveNetIncome | -30,162,000 |
| 7 | BaseVar | 28,264,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -4.23 |
| 9 | EconomicCapitalRatio | 0.337 |
Edgar->Model Mapping
Feature Distribution
